Patents by Inventor Virender Bhan

Virender Bhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic marker for interferon responsiveness in multiple sclerosis
    Patent number: 8021840
    Abstract: Disclosed is a method of determining interferon responsiveness in a patient suffering from multiple sclerosis. The method comprises determining an amount of a XAF-1 gene expression level in a blood sample, which is obtained from the patient undergoing interferon therapy. The amount of the XAF-1 gene expression level in the blood sample is then correlated with the responsiveness of the patient to the interferon.
    Type: Grant
    Filed: March 5, 2007
    Date of Patent: September 20, 2011
    Assignee: Dianovix, Inc.
    Inventors: Virender Bhan, Andrea Hebb, Martin Holcik, Robert G. Korneluk, Craig Moore, George Robertson
  • METHOD FOR DIFFERENTIATING BETWEEN MULTIPLE SCLEROSIS SUBTYPES
    Publication number: 20110136133
    Abstract: Disclosed herein is a method for differentiating between multiple sclerosis subtypes in a patient. The method comprises a) determining an amount of an IAP gene expression level in a blood sample obtained from the patient; and b) correlating the amount of the IAP gene expression level in the blood sample with the presence of a multiple sclerosis subtype in the patient.
    Type: Application
    Filed: November 17, 2010
    Publication date: June 9, 2011
    Applicant: Dianovix, Inc.
    Inventors: Virender BHAN, John Gillard, Andrea Hebb, Martin Holcik, Robert G. Korneluk, George Robertson
  • Method for differentiating between multiple sclerosis subtypes
    Patent number: 7858309
    Abstract: Disclosed herein is a method for differentiating between multiple sclerosis subtypes in a patient. The method comprises a) determining an amount of an IAP gene expression level in a blood sample obtained from the patient; and b) correlating the amount of the IAP gene expression level in the blood sample with the presence of a multiple sclerosis subtype in the patient.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: December 28, 2010
    Assignee: Dianovix, Inc.
    Inventors: Virender Bhan, John W. Gillard, Andrea Hebb, Martin Holcik, Robert G. Korneluk, George Robertson
  • Method for differentiating between multiple sclerosis subtypes
    Publication number: 20080020388
    Abstract: Disclosed herein is a method for differentiating between multiple sclerosis subtypes in a patient. The method comprises a) determining an amount of an IAP gene expression level in a blood sample obtained from the patient; and b) correlating the amount of the IAP gene expression level in the blood sample with the presence of a multiple sclerosis subtype in the patient.
    Type: Application
    Filed: February 6, 2007
    Publication date: January 24, 2008
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Virender Bhan, John Gillard, Andrea Hebb, Martin Holcik, Robert Korneluk, George Robertson
  • Diagnostic marker for interferon responsiveness in multiple sclerosis
    Publication number: 20070218493
    Abstract: Disclosed is a method of determining interferon responsiveness in a patient suffering from multiple sclerosis. The method comprises determining an amount of a XAF-1 gene expression level in a blood sample, which is obtained from the patient undergoing interferon therapy. The amount of the XAF-1 gene expression level in the blood sample is then correlated with the responsiveness of the patient to the interferon.
    Type: Application
    Filed: March 5, 2007
    Publication date: September 20, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Virender Bhan, Andrea Hebb, Martin Holcik, Robert Korneluk, Craig Moore, George Robertson